Skip to content

Investor Relations / Events & Presentations

Events & Presentations

Featured Events

There are currently no events to display.

Upcoming Events

Date Event Details Remind Me
Summary Toggle Jun 25, 2019
11:20 AM EDT

2019 BMO Prescription For Success Healthcare Conference

Archived Events

Date Event Details
Summary Toggle Jun 12, 2019
4:20 PM EDT

Goldman Sachs 40th Annual Global Healthcare Conference

Summary Toggle Jun 6, 2019
9:30 AM EDT

Jefferies 2019 Healthcare Conference

Summary Toggle May 1, 2019
7:30 AM EDT

Amarin Q1 Results Conference Call

Summary Toggle Mar 13, 2019 from 8:00 AM to 8:30 AM EDT

Cowen’s 39th Annual Health Care Conference

Summary Toggle Feb 28, 2019
9:30 AM EST

8th Annual SVB Leerink Global Healthcare Conference

Summary Toggle Feb 27, 2019
7:30 AM EST

Amarin Q4 Results Conference Call

Summary Toggle Jan 9, 2019
9:30 AM PST

Amarin Presentation at 37th Annual J.P. Morgan Healthcare Conference

Summary Toggle Dec 21, 2018

REDUCE-IT clinical trial results | Brigham and Women's Hospital, 19-DEC-2018

Summary Toggle Nov 10, 2018
8:15 PM EST

Webcast Discussion of Primary REDUCE-IT™ Trial Results Following Presentation at 2018 Scientific Sessions of American Heart Association

Summary Toggle Nov 1, 2018
7:30 AM EDT

Amarin Q3 Results Conference Call

Summary Toggle Oct 3, 2018
11:30 AM EDT

Cantor Global Healthcare Conference

Summary Toggle Sep 24, 2018
8:00 AM EDT

REDUCE-IT™ Topline Results Conference call link:

Presentations

For web links to papers supporting correlation between TG levels and cardiovascular risk, click here.

Title Date Documents

June 2019 Investor Presentation

Amarin Q1 Results Conference Call

Q1 2019 Investor Deck to Accompany Call

ACC- Physician Panel Discussion Presentation

ACC- Physician Panel Discussion

Investor Presentation SVB Leerink Global Healthcare Conference 2019

Q4 Results Conference Call Presentation Deck

Amarin Presentation at 37th Annual J.P. Morgan Healthcare Conference

Primary REDUCE-IT ™ Trial Results Presentation

REDUCE-IT Efficacy and Safety Results and Related Disclosures

Amarin Corporation